Background illustration for clinical trials search

Paid Clinical Trials Columbus

Discover 1,289 paid clinical trials in Columbus, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells

for
High Grade Glioma
Location: Columbus OH
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT04254419

Phase1, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase1, Phase2, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Myelin Disorders Biorepository Project

for
Leukodystrophy, White Matter Disease, Leukoencephalopathies,
Location: Columbus OH, Akron OH, Pittsburgh PA, Chicago IL,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT03047369

Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Columbus OH, Dayton OH, Cincinnati OH, Akron OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Combination Therapy for the Treatment of Diffuse Midline Gliomas

for
Diffuse Intrinsic Pontine Glioma,
Location: Columbus OH, Ann Arbor MI, Indianapolis IN, Chicago IL,
Sponsor: University of California, San Francisco

Sex: All

Age: 2 - 39

Code: NCT05009992

Phase2, Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for
Neoplasms, Child, Adolescent
Location: Columbus OH, Pittsburgh PA, Chicago IL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 39

Code: NCT05999994

Phase2, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Columbus OH, Dayton OH, Akron OH, Cleveland OH,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase3, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Columbus OH, Cincinnati OH, Indianapolis IN, Chicago IL,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for
Cystic Fibrosis
Location: Columbus OH, Dayton OH, Cincinnati OH, Cleveland OH,
Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

for
Duchenne Muscular Dystrophy
Location: Columbus OH, Cincinnati OH, Chicago IL, Dallas TX
Sponsor: Anne M. Connolly

Sex: Male

Age: 0 - 2

Code: NCT05412394

Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Columbus OH, Cincinnati OH, Grand Rapids MI, Toronto,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase1, Phase2, Recruiting

Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection

for
Clostridium Difficile
Location: Columbus OH
Sponsor: Jonathan Gisser

Sex: All

Age: 2 - 21

Code: NCT02134392

Phase1, Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

for
Amblyopia
Location: Columbus OH, Cincinnati OH, Cleveland OH,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4 - 7

Code: NCT06380517

Phase3, Recruiting

A Study of Uveitis in Children <18 Years of Age

for
Uveitis
Location: Columbus OH, Cincinnati OH, Akron OH, Boston MA
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 0 - 17

Code: NCT07518134

Recruiting

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for
Myopia
Location: Columbus OH, Grand Rapids MI, Chicago IL, Nashville TN,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 5 - 11

Code: NCT07095894

Phase3, Recruiting